Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...
Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback